You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Homoharringtonine

Showing 26 - 50 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax
  • combination of venetoclax and HAA regimen
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
May 29, 2023

Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML Trial in Suzhou (CAHAG regimen, Placebo regimen)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • CAHAG regimen
  • Placebo regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 10, 2021

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Leukemia, Myeloid, Chronic-Phase Trial in France (Pioglitazone, Avelumab)

Recruiting
  • Leukemia, Myeloid, Chronic-Phase
  • Angers, France
  • +22 more
Aug 6, 2020

Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with

Recruiting
  • Induction Chemotherapy
  • +3 more
  • Decitabine combined with HAAG Regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 22, 2020

Chemo Trial in Beijing (Chemotherapy)

Unknown status
  • Chemotherapy
  • Beijing, China
    Chinese PLA General Hospital
Mar 1, 2018

Leukemia Trial in Houston (Omacetaxine, Decitabine)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 9, 2018

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Acute Myeloid Leukemia, Induction Chemo Trial in Suzhou (Decitabine plus HAAG regimen, Idarubicine plus Cytarabine regimen)

Unknown status
  • Acute Myeloid Leukemia
  • Induction Chemotherapy
  • Decitabine plus HAAG regimen
  • Idarubicine plus Cytarabine regimen
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 10, 2019

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myelogenous Leukemia (AML) Trial in Atlanta (Omacetaxine)

Terminated
Has Results
  • Acute Myelogenous Leukemia (AML)
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Sep 5, 2019

Refractory Acute Myeloid Leukemia, Relapsed Acute Erythroid Leukemia, Salvage Treatment Trial in Guangzhou (HVA Regimens as

Enrolling by invitation
  • Refractory Acute Myeloid Leukemia
  • +3 more
  • HVA Regimens as Salvage Treatment
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jun 7, 2020

Leukemia Trial in Houston (Omacetaxine, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 30, 2018

CAMS(Chinese Academy of Medical Sciences)-2005 Trial and

Completed
  • Acute Myeloid Leukemia, Pediatric
  • Risk-stratified therapy
  • Tianjin, Tianjin, China
    InstituteHBDH
May 24, 2017

MDS Trial in Gainesville (Omacetaxine, Azacitidine, G-CSF)

Withdrawn
  • Myelodysplastic Syndromes
  • Gainesville, Florida
    University of Florida Health Shands Cancer Hospital
May 1, 2017

MDS Trial in Shanghai (CHG regimen, 5-aza-deoxycytidine)

Unknown status
  • Myelodysplastic Syndromes
  • Shanghai, Shanghai, China
    Shanghai 6th People's Hospital
Sep 8, 2016

Leukemia Trial in United States (hydroxyurea, Homoharringtonine)

Terminated
  • Leukemia
  • Birmingham, Alabama
  • +132 more
Jul 1, 2016

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia

Terminated
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +16 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Apr 5, 2016

Myeloid Leukemia, Chronic, Myeloid Leukemia, Chronic, Accelerated-Phase, Blast Phase Trial in Houston (Homoharringtonine,

Terminated
Has Results
  • Myeloid Leukemia, Chronic
  • +3 more
  • Homoharringtonine
  • Imatinib Mesylate
  • Houston, Texas
    Univ. of Texas M.D. Anderson Cancer Center
Jan 8, 2015

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Untreated Adult Acute Myeloid Leukemia Trial in Seoul, Ulsan (Nilotinib+AD

Unknown status
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • Untreated Adult Acute Myeloid Leukemia
  • Nilotinib+AD induction
  • Seoul, Korea, Republic of
  • +1 more
May 10, 2016

Hematologic Tumors Trial in Dallas (Omacetaxine)

Completed
  • Hematologic Tumors
  • Dallas, Texas
    Mary Crowley Cancer Research Center
May 9, 2014

Hematologic Malignancies, Solid Tumors Trial in Amsterdam (omacetaxine mepesuccinate)

Completed
  • Hematologic Malignancies
  • Solid Tumors
  • omacetaxine mepesuccinate
  • Amsterdam, Netherlands
    Teva Investigational Site 38045
Jan 29, 2015

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Boston (omacetaxine

Completed
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Chronic Phase Chronic Myelogenous Leukemia
  • omacetaxine mepesuccinate
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Harvard Cancer Center
Jun 4, 2013